Found 25 matching trials
Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029) PHASE2 The purpose of this study was to determine the appropriate dosing regimen o...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED) PHASE3 A clinical study to determine the efficacy and safety of MK0869 in the trea...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Assess the Bioequivalence of Aprepitant and Fosaprepitant and the Effect of Food on Aprepitant Bioavailability (0869-165) PHASE1 This study will assess the bioequivalence of single oral doses of aprepitan...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-063) PHASE3 A clinical study to determine the efficacy and safety of MK0869 in the trea...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-061) PHASE3 A clinical study to determine the efficacy and safety of an Treatment of MK...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED) PHASE3 A clinical study to determine the efficacy and safety of an investigational...
Show More Location
Multiple Locations
Learn More & Join Trial
2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED) PHASE3 The purpose of this study is to assess the safety and efficacy of 2 doses o...
Show More Location
Multiple Locations
Learn More & Join Trial
Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With Highly Emetogenic Chemotherapy (0869-801)(COMPLETED) PHASE4 A multicenter trial to assess the safety and efficacy of an investigational...
Show More Location
Multiple Locations
Learn More & Join Trial
An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071) PHASE4 This protocol will study an investigational drug treatment plan against sta...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208) PHASE3 This study will compare the safety and efficacy of a three-day oral aprepit...
Show More Location
Multiple Locations
Learn More & Join Trial